Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Corbacioglu S, Jabbour EJ, Mohty M.
Biol Blood Marrow Transplant. 2019 Jul;25(7):1271-1280. doi: 10.1016/j.bbmt.2019.02.018. Epub 2019 Feb 22.
Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Chan SS, Colecchia A, Duarte RF, Bonifazi F, Ravaioli F, Bourhis JH.
Biol Blood Marrow Transplant. 2020 Oct;26(10):1770-1779. doi: 10.1016/j.bbmt.2020.06.016. Epub 2020 Jun 25.
Hepatic veno-occlusive disease.
Ribaud P, Gluckman E.
Pediatr Transplant. 1999;3 Suppl 1:41-4. doi: 10.1034/j.1399-3046.1999.00077.x.
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment.
Özkan HA, Özkan SG.
Transfus Apher Sci. 2022 Feb;61(1):103372. doi: 10.1016/j.transci.2022.103372. Epub 2022 Jan 22.
Review of imaging findings in hepatic veno-occlusive disease.
Simpson S, Breshears E, Basavalingu D, Khatri G, Chan S, Fite J, Swanson P, Dighe M.
Eur J Radiol. 2024 Aug;177:111526. doi: 10.1016/j.ejrad.2024.111526. Epub 2024 Jun 3.
Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea.
Yoon JH, Choi CW, Won JH.
Korean J Intern Med. 2021 Nov;36(6):1261-1280. doi: 10.3904/kjim.2021.082. Epub 2021 Sep 24.
Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.
Günther S, Perros F, Rautou PE, Girerd B, Ghigna MR, Cazals-Hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D.
Am J Pathol. 2019 Jun;189(6):1159-1175. doi: 10.1016/j.ajpath.2019.02.007. Epub 2019 Mar 26.
Hepatic veno-occlusive disease following sirolimus-based immune suppression.
Khimani F, McDonald GB, Shulman HM, Betts B, Locke F, Fernandez H, Anasetti C, Pidala J.
Bone Marrow Transplant. 2019 Jan;54(1):85-89. doi: 10.1038/s41409-018-0233-2. Epub 2018 Jun 12.
Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH, Giralt SA.
Biol Blood Marrow Transplant. 2016 Mar;22(3):400-9. doi: 10.1016/j.bbmt.2015.09.024. Epub 2015 Oct 23.
Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG, Triplett BM, Ho VT, Chao N, Dignan FL, Maglio M, Mohty M.
Expert Rev Clin Pharmacol. 2018 Feb;11(2):113-124. doi: 10.1080/17512433.2018.1421943. Epub 2018 Jan 5.
